Latest FDA News | Page 4

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
Mesoblast option to issue up to US$50 million convertible notes for product launch
Percheron Therapeutics updates on Avicursen primate toxicology study
Nanoscope Therapeutics Licenses Optogenetic Technology
Argenica reports positive results in IND-enabling trials
Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/ß-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients…
TRUTH in Labeling Act would heighten the warning for shoppers looking to cut sugar, salt and saturated fat intake
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
PharmAust says EMA pre-submission meeting paves the way for orphan designation request
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots
Apple Watch Ultra 2 Now Available In Black Titanium
FDA’s new regulations underscore the complexity around screening for women with dense breasts
Yellow food dye can make living tissue transparent − these methods could one day improve cancer treatment, blood draws and even tattoo removal
Telix submits NDA for TLX101-CDx brain cancer imaging agent
AusBiotech 2024 National Conference Programme Unveiled
PharmAust reports positive interim study results from study in ALS
Rwanda team visits Addis Ababa for clinical trial training
De Motu Cordis (DMC) Applauds ARS Pharma’s FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in…
New agreement allows Nasodine Nasal Spray launch in Philippines
Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
What Went Wrong In 2022 Baby Formula Crisis?
Infectious diseases spike when kids return to school − here’s what you can do about it
How a Legal Loophole Allows Unsafe Ingredients in U.S. Foods
Study Finds Reliable Performance For Wireless Pacemaker
Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face
Retaining flavor while removing caffeine − a chemist explains the chemistry behind decaf coffee
Worried about the health effects of the sugar in your breakfast cereal? Little has changed since the days of ‘Unfrosted,’ the Pop-Tarts movie
Neuren secures Rare Paediatric Disease Designation from FDA
The long – and strange – history of testing menstrual blood for health conditions
Nutrition Facts labels have a complicated legacy – a historian explains the science and politics of translating food into information
Dimerix Awarded Bioshares Excellence Award
Oticon Medical’s Sentio(TM) System Receives Regulatory Clearance in the US
Orthocell receives regulatory approval to commence sales of Striate+ in Canada
Dr James Campbell Appointed AusBiotech Chair
FDA authorized the sale of menthol-flavored e-cigarettes – a health policy expert explains how the benefits may outweigh the risks
Ketamine in tablet form shown to reduce symptoms of severe depression
Ketamine slow-release tablet reduces symptoms of severe depression: clinical trial
Strengthening research ethics in clinical trials in Rwanda
No more recreational vaping for Australians. From October, vapes will be sold over the counter at pharmacies
Medical Device Regulation Changes
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
WHO and United States Food and Drug Administration extend the CRP-Lite pilot
US FDA grants rare paediatric disease designation to Race Oncology’s RC220 bisantrene
Oral nicotine pouches deliver lower levels of toxic substances than smoking – but that doesn’t mean they’re safe
Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challenges
Aussie innovators recognised at CSIRO’s ON Accelerate 8 Showcase